NCT00757835View on ClinicalTrials.gov

24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Glaucoma
Interventions
DRUG

treatment with latanoprost/timolol fixed combination

dosing in the evening with the two fixed combinations

DRUG

latanoprost/timolol fixed combination drops

once in the evening

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Aristotle University Of Thessaloniki

OTHER

NCT00757835 - 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG | Biotech Hunter | Biotech Hunter